Blue Lagoon Corp. and Landsbankinn hf. will host an open presentation on Tuesday, 10 November, at 10:00, on Blue Lagoon’s public offering of shares and its application to have all of its shares admitted to trading on the Nasdaq Iceland Main Market.
A live webcast will be available on Landsbankinn's website, landsbankinn.is/blaalonid, and on Blue Lagoon's website, blaalonidhf.is/en/investors.
The session is open to investors and the general public. Sigríður Margrét Oddsdóttir, CEO of Blue Lagoon Corp., and Elvar Þór Karlsson, Head of Corporate Finance at Landsbankinn, will present the offering and answer questions.
- The offering of shares in Blue Lagoon begins Tuesday 10 November, at 10:00 and closes at 16:00 on Friday 13 November.
- A total of 150,000,000 shares in Blue Lagoon are offered for sale, of which 45,000,000 (30%) are in Order Book A and 105,000,000 (70%) in Order Book B.
- Subscriptions ranging from ISK 100,000 to ISK 20,000,000 will be accepted in Order Book A at a price of ISK 95/share.
- Subscriptions above ISK 20,000,000 shall be submitted in Order Book B.
- The results of the offering are expected to be published no later than 16 November 2026, and the shares are expected to be delivered to buyers no later than 20 November 2026.
- The due date and final due date for payment slips relating to the offering is 18 November 2026.
- The Company's shares are expected to be admitted to trading on the Nasdaq Iceland Main Market on 20 November 2026.
Further information on the offering, subscription options and other arrangements, together with the offering documents, can be found here.
Advertisement. Please note that investing in shares involves risk. Potential investors are encouraged to read the company’s published prospectus, which has been approved by the Financial Supervisory Authority of the Central Bank of Iceland, before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the securities. The approval of the prospectus should not be understood as an endorsement of the issuer or the securities offered or admitted to trading on a regulated market.









